FDA announces urgent recall of dietary supplement due to undeclared ingredients

The FDA says manufacturer StuffbyNainax LLC is voluntarily recalling all lots of MR.7 SUPER 700000 capsules after an analysis by the FDA showed the capsules contained sildenafil and tadalafil, the active ingredients used to treat male erectile dysfun

The FDA says manufacturer StuffbyNainax LLC is voluntarily recalling all lots of MR.7 SUPER 700000 capsules after an analysis by the FDA showed the capsules contained sildenafil and tadalafil, the active ingredients used to treat male erectile dysfunction.  Sildenafi is sold as Viagra and Revatio and tadalafil is sold as Cialis.    

What we know:

The FDA says manufacturer StuffbyNainax LLC is voluntarily recalling all lots of MR.7 SUPER 700000 capsules after an analysis by the FDA showed the capsules contained sildenafil and tadalafil, the active ingredients used to treat male erectile dysfunction.  

Why you should care:

The consumption of sildenafil or tadalafil may cause serious health risks for people taking certain prescription medications.  The FDA says nitrate is found in certain medications to treat diabetes, high blood pressure, high cholesterol, and heart disease.  Sildenafil or tadalafil may interact with the nitrates leading to a dangerous drop in blood pressure, which can be life‑threatening.  

Dig deeper:

The FDA says MR.7 SUPER 700000 was marketed as a dietary supplement for male enhancement and distributed nationwide to a limited number of online customers between August 2025 and November 2025. The affected product does not have lot numbers or expiration dates. 

Product Name: MR.7 SUPER 700000
Brand: MR.7
Form: Capsules
Lot Number: Not available / unlisted
Distribution Period: August 2025 – November 2025
Distribution: Sold online in the United States

What you can do:


Consumers can contact the company by phone at 346- 441-9470 or via email at stuffbynainaxllc.info@gmail.com 

The Source: Information in this article was provided by the Food and Drug Administration (FDA).  This story was reported from Orlando.


 

ConsumerHealth